2.165RON+2.36%Mkt Cap: 317.55M $P/E: 43.301d ago
Antibiotice S.A. produces and sells medicinal products in Romania and internationally. The company provides generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, as…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/E
Pricier
P/B
Avg
Div Yield
Higher
1M Perf
Avg
Indicators:|
Key Statistics
Company
Market Cap317.55M $
Enterprise Value385.60M $
Revenue (TTM)139.60M $
Gross Profit92.39M $
Net Income (TTM)11.31M $
Revenue/Share0.2080 USD
Last Price2.165 RON
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.4K
CountryRO
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINROATBIACNOR9
Valuation
P/E (Trailing)43.30
P/E (Forward)—
PEG3.89
EV/EBITDA16.97
EV/Revenue2.76
P/S2.27
P/B1.54
EPS (TTM)0.05
EPS (Forward)—
52W Range
1.75242% of range2.725
52W High2.725 RON
52W Low1.752 RON
Profitability
Gross Margin65.53%
Oper. Margin9.61%
EBITDA Margin16.28%
Profit Margin8.02%
ROE5.55%
ROA3.72%
Growth
Revenue Growth-12.90%
Earnings Growth-61.50%
Cash Flow & Leverage
Operating CF15.83M $
CapEx (TTM)31.16M $
FCF Margin-21.94%
FCF Yield-9.65%
Net Debt68.05M $
Net Debt/EBITDA2.99
Balance Sheet
Debt/Equity0.25
Current Ratio1.83
Quick Ratio1.08
Book Value/Sh1.407 RON
Cash/Share0.0030 RON
Dividends
Fwd Div Rate0.0200 RON
Trail. Div Rate0.0360 RON
Div. Yield0.97%
5Y Avg Yield1.40%
Payout Ratio43.55%
Ex-Div DateSep 25, 2025
Pay Date—
Splits
Last Split1.18192:1
Split DateJul 11, 2013
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.671.34M
Float227.94M
Insiders58.05%
Institutions13.63%
Technical
SMA 501.999 (+8.3%)
SMA 2002.234 (-3.1%)
Beta0.25
S&P 52W Chg20.05%
Avg Vol (30d)184.86K
Avg Vol (10d)117.79K
Technical Indicators
RSI (14)67.0
MACD0.0344
MACD Signal0.0286
MACD Hist.+0.0058
BB Upper2.177 RON
BB Middle2.065 RON
BB Lower1.953 RON
BB Width10.87%
ATR (14)0.0501 RON
Vol Ratio (20d)1.06x